Cargando…

Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease

AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, S. M. V., Foroutan, H. R., Zeraatian, S., Sabet, B.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788448/
https://www.ncbi.nlm.nih.gov/pubmed/20011471
http://dx.doi.org/10.4103/0971-9261.43025
_version_ 1782174978014183424
author Hosseini, S. M. V.
Foroutan, H. R.
Zeraatian, S.
Sabet, B.
author_facet Hosseini, S. M. V.
Foroutan, H. R.
Zeraatian, S.
Sabet, B.
author_sort Hosseini, S. M. V.
collection PubMed
description AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with absent anorectal inhibitory reflex, rectosigmiod disease in Barium enema, positive Acetylcholine esterase (Ache) staining, good response to rectal washout. They underwent botulinium toxin injection (5 unit /kg/quadrant) in four quadrant intrasphincteric. They were followed until pull through operation in 8-10 weeks post injection. RESULTS: Four of 8 (50%) cases only needed rectal washout for three to five days post injection until pull through operation, two had decrease in number of rectal washouts /day and the remaining two underwent colostomy five days post injection because of no response. CONCLUSION: Botulinium toxin injection can help in palliative care in patients with Hirschsprung disease who are waiting for colostomy or definitive pullthrough. It gives an option of eaiser home care for these patients.
format Text
id pubmed-2788448
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27884482009-12-13 Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease Hosseini, S. M. V. Foroutan, H. R. Zeraatian, S. Sabet, B. J Indian Assoc Pediatr Surg Original Article AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with absent anorectal inhibitory reflex, rectosigmiod disease in Barium enema, positive Acetylcholine esterase (Ache) staining, good response to rectal washout. They underwent botulinium toxin injection (5 unit /kg/quadrant) in four quadrant intrasphincteric. They were followed until pull through operation in 8-10 weeks post injection. RESULTS: Four of 8 (50%) cases only needed rectal washout for three to five days post injection until pull through operation, two had decrease in number of rectal washouts /day and the remaining two underwent colostomy five days post injection because of no response. CONCLUSION: Botulinium toxin injection can help in palliative care in patients with Hirschsprung disease who are waiting for colostomy or definitive pullthrough. It gives an option of eaiser home care for these patients. Medknow Publications 2008 /pmc/articles/PMC2788448/ /pubmed/20011471 http://dx.doi.org/10.4103/0971-9261.43025 Text en © Journal of Indian Association of Pediatric Surgeons http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hosseini, S. M. V.
Foroutan, H. R.
Zeraatian, S.
Sabet, B.
Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title_full Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title_fullStr Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title_full_unstemmed Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title_short Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
title_sort botulinium toxin, as bridge to transanal pullthrough in neonate with hirschsprungs disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788448/
https://www.ncbi.nlm.nih.gov/pubmed/20011471
http://dx.doi.org/10.4103/0971-9261.43025
work_keys_str_mv AT hosseinismv botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease
AT foroutanhr botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease
AT zeraatians botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease
AT sabetb botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease